Prosecution Insights
Last updated: July 17, 2026

Kramer & Amado, P.C.

13 pending office actions • 11 clients • 12 examiners • 8 art units • 0 of 13 (0%) have an AI response strategy ready • 17 patents granted in the last 365 days

Quality Metrics (n=24102 apps, methodology: how we score firms)

89.0%
Allowance Rate
n=24102
+0.69σ
Allowance Rate (norm)
n=24102
3.9
OAs to Allowance
n=15356
+0.10σ
OAs to Allow (norm)
n=15356
1118 days
Time to Allowance
n=15356
+5.8pp
Interview Lift
n=24102
34.2%
RCE Rate
n=24102
2.8%
Appeal Rate
n=24102

Rejection Performance (% of received rejections ultimately overcome)

84.4%
§101 Overcome
n=729
86.5%
§102 Overcome
n=2169
82.9%
§103 Overcome
n=10977
88.1%
§112 Overcome
n=1964

Specialization & Scale

G06Q, H04L, G06F
Top CPC Subclasses
9%
Top-3 CPC Share
n=24102
6
Practitioners
n=24102
4017.0
Apps / Practitioner
n=24102

Portfolio Summary

13
Total Pending OAs
6
Non-Final OAs
6
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

6
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (6)Due ≤ 60 days (1)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (8%)
10
Medium (77%)
2
Easy (15%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (8%)
§103 only8 (62%)
§102 only2 (15%)
§112 only2 (15%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

11
Life Sciences
85% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
15% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

130 h
Manual time on pending OAs
26 h
Time saved (low, 20%)
46 h
Time saved (mid, 35%)
1.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MACFARLANE, STACEY NEE 2 53.3% +39.3%
DUFFY, PATRICIA ANN 1 52.7% +34.2%
BAZARGANI, ARYA AHMADI 1 66.7% +0.0%
GONZALEZ, LUISALBERTO 1 59.9% +47.1%
SAMSELL, RILLA MARIE 1 72.4% +14.7%
SPAINE, ROBERT FRANKLIN 1 100.0% +0.0%
FIORELLO, BENJAMIN F 1 73.9% +7.3%
BOECKELMAN, JACOB A 1 36.2% +46.0%
MOORE, SUSANNA 1 68.0% +31.6%
ADDIE, RAYMOND W 1 81.4% +8.1%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17507961 ROAD PLATE MOVING SYSTEM AND METHOD ADDIE, RAYMOND W 15d overdue
17905564 SYNERGISTIC COMPOSITIONS FOR IMPROVING BRAIN HEALTH SPAINE, ROBERT FRANKLIN

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
14346822 STIMULUS-ELICITED GENOMIC PROFILE MARKERS OF A NEURODEGENERATIVE CONDITION FONTAINHAS, AURORA M 18d overdue

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
17066961 FIBROBLAST GROWTH PATTERNS FOR DIAGNOSIS OF ALZHEIMER'S DISEASE MACFARLANE, STACEY NEE 74d overdue
18054285 Compositions Comprising Human Skin Fibroblasts and Amyloid Beta Peptide MACFARLANE, STACEY NEE 70d overdue
17609935 METHOD FOR SYNTHESIZING 25-OH CHOLESTEROL/CALCIFEDIOL FROM PHYTOSTEROL MOORE, SUSANNA 8d overdue
17554636 COMPOSITION FOR ENHANCEMENT OF BIOAVAILABILITY OF PHYTOCHEMICALS AND PROCESS FOR PREPARATION THEREOF BOECKELMAN, JACOB A 5d overdue
18250853 PROCESS FOR PREPARATION OF PURE NALTREXONE DECANOATE, ITS SALTS, COMPOSITION AND METHOD OF USE THEREOF SAMSELL, RILLA MARIE 53d
18483888 CROSS-PROTECTIVE ANTIGENS FOR VACCINATION DUFFY, PATRICIA ANN
18256295 BIO PESTICIDAL COMPOSITION CONTAINS NOVEL NONANOATE ESTERS OF SUGARS AND SUGAR ALCOHOLS TO CONTROL LEPIDOPTERA, HEMIPTERA AND THYSANOPTERA INSECTS GONZALEZ, LUISALBERTO

Client Portfolio (11 clients)

Top Art Units

Art UnitApps
16243
16753
16552
16451
16131
36781
36711
16531

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18483888 CROSS-PROTECTIVE ANTIGENS FOR VACCINATION The West Virginia University Board Of Governors On Behalf Of West Virginia University DUFFY, PATRICIA ANN 1645 §102 Non-Final OA Pending Oct 10, 2023
18547044 NON-AQUEOUS INJECTABLE COMPOSITION OR SUSTAINED RELEASE OF BUPRENORPHINE AND USE THEREOF Navin Saxena Research And Technology Private Limited BAZARGANI, ARYA AHMADI 1613 §103 Final Rejection Pending Aug 18, 2023
18256295 BIO PESTICIDAL COMPOSITION CONTAINS NOVEL NONANOATE ESTERS OF SUGARS AND SUGAR ALCOHOLS TO CONTROL LEPIDOPTERA, HEMIPTERA AND THYSANOPTERA INSECTS Fertis India Pvt. Ltd. GONZALEZ, LUISALBERTO 1624 §103 Non-Final OA Pending Jun 07, 2023
18250853 PROCESS FOR PREPARATION OF PURE NALTREXONE DECANOATE, ITS SALTS, COMPOSITION AND METHOD OF USE THEREOF Navin Saxena Research & Technology Pvt. Ltd. SAMSELL, RILLA MARIE 1624 §103 Final Rejection 53d Pending Apr 27, 2023
18054285 Compositions Comprising Human Skin Fibroblasts and Amyloid Beta Peptide West Virginia University MACFARLANE, STACEY NEE 1675 §103 Final Rejection 70d overdue Pending Nov 10, 2022
17905564 SYNERGISTIC COMPOSITIONS FOR IMPROVING BRAIN HEALTH Laila Nutrceuticals SPAINE, ROBERT FRANKLIN 1655 §103 Non-Final OA Pending Sep 02, 2022
17826919 FLEXIBLE ROPE NET GABION Garware Technical Fibres Ltd. FIORELLO, BENJAMIN F 3678 §112 Non-Final OA 69d Pending May 27, 2022
17554636 COMPOSITION FOR ENHANCEMENT OF BIOAVAILABILITY OF PHYTOCHEMICALS AND PROCESS FOR PREPARATION THEREOF Olene Life Sciences Private Limited BOECKELMAN, JACOB A 1655 §103 Non-Final OA 5d overdue Pending Dec 17, 2021
17609935 METHOD FOR SYNTHESIZING 25-OH CHOLESTEROL/CALCIFEDIOL FROM PHYTOSTEROL Fermenta Biotech Limited MOORE, SUSANNA 1624 §103 Non-Final OA 8d overdue Pending Nov 09, 2021
17507961 ROAD PLATE MOVING SYSTEM AND METHOD Fer-Pal Construction, Ltd. ADDIE, RAYMOND W 3671 §103 Final Rejection 15d overdue Pending Oct 22, 2021
17066961 FIBROBLAST GROWTH PATTERNS FOR DIAGNOSIS OF ALZHEIMER'S DISEASE West Virginia University MACFARLANE, STACEY NEE 1675 §112 Final Rejection 74d overdue Pending Oct 09, 2020
15107152 CONVERGENCE OF AGGREGATION RATE WITH VALIDATED PERIPHERAL DIAGNOSTIC FOR ALZHEIMER'S DISEASE West Virginia University NGUYEN, NGHI V 1653 §102 Final Rejection 69d Pending Jun 22, 2016
14346822 STIMULUS-ELICITED GENOMIC PROFILE MARKERS OF A NEURODEGENERATIVE CONDITION West Virginia University FONTAINHAS, AURORA M 1675 §101 Non-Final OA 18d overdue Pending Mar 24, 2014

Managing Kramer & Amado, P.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month